motherapy were listed as cyst rupture, multiple lesions in the CNS, multiple system or organ involvement, cyst recurrence, and preoperative need for cyst volume reduction. Obviously, our colleagues were allowed to check multiple options if they used chemotherapy for more than one indication. Other questions concerned the rate of extraneural involvement and the system(s) affected, the chemotherapeutic agents and dose, cyst recurrence, and morbidity and mortality rates.
Literature Review
This phase of the study included a search of all reports published by Turkish authors during the 20th century. We used a Medline survey, personal contact, the Turkish Biblioindex, 3 and national library and parliamentary library periodicals to undertake this review.
Statistical analysis was performed using a test of significant difference between two independent properties.
Results

Results of the Cooperative Study
The results of questionnaires completed by 47 neurosurgical units indicated that nine centers had encountered no case of hydatidosis during the past 5 years. The total numbers of cases seen by the remaining 38 centers, including our own (see Appendix for participating institutions), are listed in Table 1 . Regarding the treatment of both cranial and spinal hydatid cysts (140 cranial and 63 spinal), Dowling's technique was used in 187 cases (92.12%). Careful puncture and aspiration of cyst contents, followed by total extirpation of the cyst wall, was performed when total removal seemed difficult and hazardous. This surgical method was used in 15 cases (7.39%) of hydatid cyst. Total extirpation of multiple sacral lesions was performed using endoscopy successfully in only one case of a spinal cyst. 1 Of the 35 centers that reported the use of chemotherapy for at least one indication, 30 preferred a regimen of albendazole. Only five centers reported administration of mebendazole as the chemotherapeutic agent. Based on the drug regimens mentioned on the questionnaires, there was no common protocol for either agent. Table 2 lists the range of chemotherapy indications that were reported. Extraneural involvement of hydatidosis was observed in 53 cases (24.2%), and cases of both single and multiple organ or system involvement were reported. Because the incidence of CNS hydatidosis is only 2 to 3%, and the CNS is typically a secondary site, the aforementioned figure seems lower than expected. Table 3 lists the reported sites of extraneural involvement.
Results of the Literature Survey
We present the results of the literature survey on CNS hydatidosis in Turkey by differentiating the cysts into three types: intracranial hydatid cysts, spinal hydatid cysts, and intracranial alveolar cysts.
Intracranial Hydatid Cysts. The information on this type of cyst was derived from 52 publications, 36 of which were written in English and 16 in Turkish. The distribution of the reports according to decades was as follows: one report from the 1940s, four reports from the 1950s, two from the 1960s, three from the 1970s, seven from the 1980s, and 35 from the 1990s. The total number of reported cases was 336. There were 202 male (60.12%) and 134 female (39.88%) patients. Table 4 lists the patients according to age group. Solitary cysts were diagnosed in 282 patients (83.93%) and multiple cysts in the remaining 54 (16.07%). Intracranial cyst locations are noted in Table 5 . There were no specific signs and symptoms associated with intracranial hydatid cysts. Symptoms depended on the location of the lesion and varied widely from simple headache to uncal herniation. The diagnostic tools used N. Altınörs, et al. Table 3 . The therapy selected was mainly surgical, with 330 of the 336 patients undergoing operations. Six patients died before any diagnostic or surgical intervention was undertaken. One cyst was punctured accidentally during ventriculography and the patient died. In these six cases, the diagnosis was made at autopsy. The surgical method known as Dowling's technique requires total removal of the cyst by hydrostatic expulsion, that is, by forcing saline solution around and beneath the cyst. 7 This technique was executed successfully in 207 cases (61.61%). In 86 cases (25.6%), the cysts ruptured inadvertently during surgical manipulation. In 35 cases (10.42%), the cyst was punctured, its contents were aspirated, the cystic cavity was irrigated with a hypertonic solution, and the shrunken cyst wall was extirpated. This method is known as PAIR. In two cases, air was insufflated into the ventricles to abort the cysts. 39 Chemotherapy was used for a variety of indications and Table 2 summarizes these. Recurrence was reported in 56 patients (16.67%) in different periods postoperatively. Two patients experienced two recurrences, seven patients had three, and two patients had four. In 32 patients the therapy for the recurrences was repeated surgery. In 22 cases chemotherapy was combined with surgery. In one patient a combination of surgery, chemotherapy, and radiotherapy was used. We have no data on the therapy used in the remaining patient. A variety of postoperative complications were encountered in 32 patients (9.52%) ( Table 6 ). There were 34 deaths in patients with intracranial hydatid cysts, accounting for an overall mortality rate of 10.12% (34 of 336). The surgical mortality rate was 8.48% (28 of 330). The causes of death in 21 patients are listed in Table 7 .
Spinal Hydatid Cysts. Information on patients with spinal hydatid cysts was derived from 38 reports and includes 111 cases. Turgut 42 published a comprehensive review of spinal hydatid disease in Turkey in 1997. Of the 111 patients, 73 (65.77%) were male and 38 (34.23%) were female. There were three reports from the 1940s, four from the 1950s, two from the 1960s, one from the 1970s, six from the 1980s, and 22 from the 1990s. Table 4 lists patients with this disease according to age group. For diagnostic purposes, x-ray films were used in 100 patients, myelography in 64, MR imaging in 24 patients, CT scanning in 14 patients, and CT myelography, ultrasonography, and electromyography in one patient each. Information on lesion location was available for 99 patients; a summary of these data can be found in Fig. 1 . Morbid conditions were encountered in 14 patients (12.61%), and four individuals (3.6%) died. One death was related to renal involvement and eventual renal failure. Another was caused by a dural tear through which the passage of hypertonic solution caused a toxic effect. 21 Recurrence occurred in 24.32% of patients with spinal cysts. Chemotherapy was used in 60.36% of the 111 cases, and extraspinal involvement was diagnosed in 14.41% of the affected individuals.
Intracranial Alveolar Cysts. Seven publications listed this type of cyst, with a total of 11 cases, nine men and two women. The youngest patient was aged 26 years and the oldest was 60 years; the mean age of patients was 40.81 years. Diagnosis was made by CT scanning in five patients, by MR imaging in two patients, and by angiography in four patients. Two lesions were found in the cere-
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Central nervous system hydatidosis in Turkey 3 bellum; all others were located in the supratentorial region, with no specific site. In all cases, the surgical procedure was total removal of the lesion. In four patients, multiple cysts were diagnosed. Two patients had two lesions each, and, in both cases, the masses were removed totally in separate craniotomies. In one patient who had four cysts, only one mass was excised. The stereotactic technique was used to obtain a biopsy sample from one of the multiple lesions in another patient. Systemic investigation for extraneural alveolar cysts was conducted in all patients. Studies revealed the presence of a liver cyst in eight patients and pulmonary cysts in two patients. One patient had renal involvement. In two individuals, abdominal ultrasonography did not reveal any liver cyst. In one patient, needle biopsy demonstrated vacuolar degeneration. Chemotherapy (administration of mebendazole in five patients and albendazole in two patients) was used in seven patients. Two patients (18.18%) died, both of whom had refused laparotomy for removal of their liver cysts. These patients succumbed to liver failure nearly 3 years after the initial diagnosis. 41 One patient experienced recurrence of two previously removed intracranial lesions and had two new lesions when his condition deteriorated and he died. 4 An overall summary of the basic data derived from the cooperative study and from the literature survey is outlined in Table 8 .
Discussion
The problems encountered in managing hydatidosis are best discussed under two main headings: diagnosis and therapy.
Diagnostic Difficulties
The issue of diagnosis should be considered by comparing the pre-CT/MR imaging and CT/MR imaging eras. Skull x-ray films, electroencephalography,
99
Tc scintigraphy, ventriculography, and angiography were all used during the earlier period; however, the diagnostic specificity of these procedures is low. Furthermore, cyst puncture can occur during ventriculography 24 and can result in death. 19 Computerized tomography and MR imaging not only have tremendously increased diagnostic specificity, but have also allowed us to visualize the outermost margin of the cyst, thus helping the surgeon to plan the cortical incision and accurately approach the lesion. 32 On CT scans, hydatid cysts are demonstrated as well-defined intraparenchymal cystic lesions that are often spherical in shape, with cystic fluid that appears to have the same density as CSF and with no perilesional edema (Fig. 2) . Generally, the lesions do not display enhancement, but peripheral rim enhancement may be observed in the fibrous capsule after intravenous administration of contrast medium. Calcifica-N. Altınörs, et al. (Fig. 3) . 2, 5, 14 Even with the advances of CT and MR imaging, certain diagnostic problems remain. Some of these are related to changes in cyst structure, which can generate CT scans that differ considerably from classic images. These include infectious changes in the cyst 16, 19 and dead cysts. 44 In cases that involve multiple lesions, smaller cysts located in and among larger ones may go undetected, even on CT and MR images. These are thin-walled cysts that can easily rupture during surgery. The six patients who died before undergoing any neurodiagnostic procedure were mentioned in reports from the 1950s and 1960s. If CT scanning had been available during that time period, these patients' cysts certainly would have been diagnosed, and the patients would have undergone surgery and, most likely, survived.
Therapeutic Difficulties
This aspect of management should be addressed by recounting why we treat these pathological lesions. First, although they are nonneoplastic, hydatid cysts are spaceoccupying lesions that produce signs and symptoms due to their mass effect. This effect may increase over time as the cyst grows. Several observations have been made about the growth rate of hydatid cysts. Sierra, et al., 37 reported a rate of 5 cm/year in a patient with secondary cysts. Evliyaoglu and coworkers 18 observed a rate of 1 cm/ month over a 6-month period, and in a report based on CT results a rate of 10 cm/year was given. 35 Our own experience revealed a growth rate of 7 mm/month (Figs. 4  and 5) .
In addition to the problems that are associated with their growth, hydatid cysts can rupture either spontaneously, 12, 30 as a result of trauma, or during surgery. Two types of complications are associated with rupture: development of multiple cysts afterward and a serious anaphylactic reaction induced by spillage of intracystic fluid. Surgery is the first and an effective option for treating intracranial hydatid cysts. The aim is removal of the entire cyst(s) without rupture. Location and multiplicity are the two main problems faced by surgeons in treating this disease. 5, 29 Lesions at deep locations, cysts in eloquent areas, and sites bounded by bone tissue pose barriers to total removal of cysts. Examples of such sites are the pons, 15 thalamus, 17 cavernous sinus, 23 sylvian aqueducts, 20 and the intrasellar region. 31 As we noted earlier, multiplicity of cysts makes an accurate diagnosis difficult because small cysts clustered with larger ones may be missed even when CT and MR imaging are used. Also, the development of cysts at different locations necessitates multiple craniotomies. Furthermore, multiple cysts are separated by septumlike bands of glial tissue, which makes total removal difficult. Spinal hydatid cysts have been classified into three main subgroups: paraspinal, spinal, and intraspinal lesions. Intraspinal lesions are either extradural, intradural, or intramedullary. 11 Vertebral involvement is common in the spinal form of the disease, and such cysts have the disadvantages of being microvesicular, invasive, and often multiple in nature. 10 Such features create problems for total removal as well as increase the incidence of rupture and, consequently, that of recurrence. A recurrence rate of 40% has been reported for cases in which treatment is delayed, 43 and the incidence of paraplegia due to recurrent disease is reported to be 25 to 45%. Surgical treatment of spinal hydatid disease is more problematic than that of intracranial cysts. The two main reasons for this are: spinal cysts are localized in a rather narrow space with close bony boundaries that cause frequent intraoperative ruptures. This fact is reflected in our cooperative study. The intraoperative rupture rate for cranial lesions is 16.91%, whereas that for spinal cysts is 44.44% (Table 8 ). The second reason is that multiplicity is more common in spinal lesions. There is no specific surgical technique to avoid this complication. Most lesions rupture during laminectomy, especially if there is extradural localization.
The incidence of intracranial alveolar cysts is extremely low compared with that of hydatid cysts of the brain, and only a limited number of cases are reported in the literature. 4, 8, 34, 41, 45 The liver is infested initially, followed by hematogenous spread to distant organs including the brain. Such metastasis is an ominous development. The infection forms hard masses of an infiltrative nature in the involved organs. Surgery and chemotherapy are the principal forms of treatment in cases of hydatid disease. Schmid and coworkers 36 reported a case of an inoperable cerebral alveolar cyst in which a gamma knife was used in two sessions, along with repeated courses of mebendazole. Those authors observed notable clinical and radiological improvement and have proposed gamma knife radiosurgery as an alternative treatment for poor surgical candidates. Chemotherapy is the second or adjuvant form of treatment and is currently being used more often. Intraoperative rupture or puncture of the hydatid cyst, recurrence, multiple and disseminated lesions, preoperative cyst volume reduction, prophylactic use, and poor surgical candidacy are the indications mentioned. Authors have reported successful treatment of intracranial hydatid cysts, even multiple lesions, in cases treated with albendazole alone. 22, 38 Lam, et al., 25 reported that drug therapy was effective in a patient who had inoperable spinal hydatidosis.
No mention of side effects of mebendazole or albendazole has been made either in the literature survey or in the cooperative study. The side effects related to these benzimidazole carbamates have included: elevated serum glutamic-oxaloacetic transaminase and serum glutamicpyruvic transaminase, abdominal pain, headache, distension, vertigo, urticaria, jaundice, alopecia, thrombocytopenia, tachycardia, dyspepsia, and fever. 40 We found only two reports in which radiotherapy is used as an adjuvant therapy in the treatment of hydatid disease. 19, 23 To interpret the results of the cooperative study and those of the literature survey, we should start by examining the prevalence of this disease. Official statistics provided by the Turkish Ministry of Health 27 on the total number of hydatid cysts are listed in Table 9 . The figures in this table show that there has been no decrease in the incidence of the disease in the recent past. Based on the fact that approximately 2 to 3% of cases of hydatid disease involve the CNS and interpolating figures from Table 9 , we would expect 65 to 70 cases of CNS hydatidosis per year in Turkey. Our cooperative study indicated that 219 such patients had been seen during the last 5 years. Once cases from nonteaching centers, which were not included in the study, are added to this sum, the figures agree quite closely. The intraoperative rupture rates for intracranial hydatid cysts were 16.91% and 25.59% in the cooperative study and literature survey, respectively. The difference N. Altınörs, et al. FIG. 5. Coronal (left) , axial (center), and sagittal (right) MR images obtained in the same case as that shown in Fig. 4 . The images, which were obtained at the authors' center 9 months after the initial CT scan, demonstrate obvious growth of the cyst, which has new dimensions of 8.2 ϫ 6 ϫ 5.5 cm (growth rate of 7 mm/month). between these figures is not statistically significant. The morbidity and mortality rates for intracranial hydatid cysts in the cooperative study (5.14% and 4.28%, respectively) seem somewhat better than the corresponding rates found in the literature survey (morbidity rate 9.52%, overall mortality rate 10.12%, surgical mortality rate 8.48%), but there was no statistical difference between these two groups of figures either. There was also no statistically significant difference between the recurrence rate provided by the cooperative study and that found in the literature survey. However, the frequency of chemotherapy administration did differ statistically between the two sets of results, with the cooperative study indicating greater usage (t = 9.16, p Ͻ 0.05). This may also be related to the improved morbidity and mortality figures noted in the cooperative study. The cooperative study reflects the experience of colleagues during the period from 1994 to 1999, which correlates well with the more frequent use of chemotherapy for a wider range of indications. Another statistically significant parameter was extraneural involvement in the disease (t = 2.97, p Ͻ 0.05). Again, this finding is predictable because CNS hydatidosis usually arises secondarily, after entry of the parasites at distant sites, and later spreads. In recent years, modern diagnostic tools used to scan for foci throughout the body have yielded higher percentages of extraneural involvement, as revealed by the results of the cooperative study. This makes sense for the true nature of the disease. With regard to results in patients with spinal hydatid cysts, we found that administration of a chemotherapeutic drug was the only statistically significant parameter (t = 3.78, p Ͻ 0.05); with the rate of chemotherapy higher in the cooperative study. The morbidity, mortality, and recurrence figures found in the cooperative study and the literature survey were not statistically significant.
The current management of hydatid disease has not changed greatly. The principal mode of treatment is surgical. Dowling's technique is the preferred surgical approach. The accepted procedure in cases of intraoperative rupture is aspiration of the cyst contents, extirpation of the cyst wall, and, as a precaution, extensive irrigation of the surgical field with a hypertonic solution to prevent recurrence.
With the PAIR technique, the puncture is a planned procedure and the method is mainly used for cysts whose locations pose a potential risk of rupture. Examples of such locations are the orbit, sella, thalamus, and pons.
The use of endoscopy in the evacuation of spinal cysts 1 and the beneficial effects of gamma knife radiosurgery in treating intracranial alveolar cysts 36 may be promising surgical alternatives.
Development of more effective chemotherapeutic agents that carry fewer side effects might be important in the conservative treatment of hydatidosis. Even using the presently available compounds, chemotherapy may be the initial form of treatment for small and multiple cysts located in eloquent areas of the brain in patients with no or minimal neurological deficits. Encouraging experiences with chemotherapy 22, 25, 38 prompt us to make such a suggestion. Patients not responding to chemotherapy can be considered as surgical candidates, especially if they are experiencing progressive neurological signs and symptoms.
